|
| |
Lecture
5
Spread
and Replication
Reading: pg. 157 –165
-
Surface vs. systemic infection (fig. 15.1, pg. 157, fig.
15.2, fig. 15.3, pg. 158)
-
Replication rates (fig. 15.6, pg. 159)
-
Mechanisms of spread
-
Spread to lymph and blood (fig. 15.7, pg. 160)
-
Spread from blood
-
Spread via nerves (fig. 15.9, pg. 161)
-
Spread via cerebrospinal fluid
-
Spread via other routes
-
Genetic determinants of spread
-
Other
factors
-
Molecular basis (fig. 15.11, pg. 164)
-
Host
factors (fig. 15.12, pg. 165
Parasite Survival
Strategies, etc Reading: pg. 167 – 180
-
Strategies to
evade innate defenses
-
Killing or
avoiding being killed by phagocytes (fig. 16.1, pg. 168)
-
Interfering
with ciliary action
-
Interfering
with complement’s alternative pathway (fig. 16.2, pg.
169)
-
Producing iron
binding molecules
-
Blocking
interferons
-
Strategies to
evade adaptive defenses
-
Immunosuppression
-
Persistent
infections
-
Reactivation
Pathologic consequences of infection Reading: pg. 183 –
197
-
General scheme (fig. 17.1, pg. 183)
-
Pathology caused directly by microorganism
-
Direct tissue damage (fig. 17.2, pg. 184)
-
Exotoxins of importance (fig. 17.3, pg. 185)
-
Pathologic activation of natural immune mechanisms (fig.
17.6, pg. 188)
-
Pathologic consequences of the immune response
-
Hypersensitivity (fig. 17.8, pg. 191)
-
Cell-mediated responses (fig. 17.11, pg. 193)
-
Skin
rashes (fig. 17.12, pg. 194)
-
Viruses and cancer (fig. 17.13, pg. 195, fig. 17.14, pg.
195)
Pathology of Infection
(p. 157-197)
Spread and replication
Parasite survival Strategies
Pathologic consequences of infection
Spread and Replication: Surface vs.
systemic infection
p
Determining
factors
n
Temperature –
temperature-sensitive microbes
p
Rhinoviruses
p
Mycobacterium leprae
n
Site of budding
p
Influenza and parainfluenza viruses (fig.15.2)
Spread and Replication: Surface vs.
systemic infection
p
Many microbes
have to invade deeper tissue
n
fail to spread and multiply at
site of initial infection
p
Measles and typhoid
n
route of infection is different
from site of replication and shedding.
p
Mumps - infect via respiratory route; multiply
in salivary glands
p
hepatitis A - infect via alimentary route;
multiply in liver
Spread and Replication: Replication rates
p
Varies from 20 min to weeks
in vitro
p
Microbes multiply faster in
vitro than in vivo
Spread and Replication: Mechanisms of
spread
p
Spread to lymph
and blood
n
microbes encounter a variety of
defenses:
p
Tissue fluids with antimicrobial substances
(antibody, complement)
p
Local macrophages (subcutaneous and submucosal)
p
Physical barrier of local tissue structure –
prevents spreading
p
Lymphatic system – where phagocytes and other
defenses awaits (fig. 15.7)
Spread and Replication: Mechanisms of
spread
p
Spread from
blood
n
Viremia and bacteremia
n
Microbes may be:
p
free – exposed to immune defenses
p
Associated with circulating cells - protect
and carry them around body
§
Epstein-Barr virus and rubella,
and intracellular bacteria (Listeria, Brucella)
– protected inside lymphocytes or monocytes
§
Malaria - erythrocytes
n
Microbes invade only certain
organs and tissues:
p
Specific receptors for microbe
p
Random localization
p
Accumulation of circulating microbes in areas
with local inflammation
n
Microbe shed from body surface
or into bloodstream
Spread and Replication: Mechanisms of
spread
p
Spread from nerves
n
Viruses reach CNS via axons
n
Few host defenses to control
viral spread
n
Fig. 15.9: routes of invasion
of the CNS
n
Uncommon route of spread to CNS
p
olfactory nerves
§
Amoeba in freshwater
pools - causes meningoencephalitis in swimmers
p
Viruses and bacteria in nasopharynx
§
Meningococci, poliovirus
p
Spread from cerebrospinal fluid
n
After crossing
blood-cerebrospinal barrier microbes can:
p
invade neural tissues – echovirus, mumps virus
p
Multiply locally and infect ependymal and
meningeal cells – N. meningitidis, H. influenzae
p
Spread via other routes
n
organ to organ via pleural or
peritoneal cavity
n
Infections of:
p
peritoneal cavity - injury or disease of
abdominal organs
p
Pleural cavity – chest wounds or lung
infections
Spread and Replication: Genetic
determinants of spread
p
host genetic determinants
n
Affect susceptibility to
pathogens
n
Example: Sickle cell gene
p
Wildtype
p
Sickle cell gene - nucleotide change in DNA
§
Sickle cell trait
(heterozygous form)
§
confers resistance to severe
forms of malaria
§
selected for in malarial
regions of world
p
Microbial genetic determinants
n
Virulence factors:
p
encoded by microbial genes
p
Includes adhesion, penetration into cells,
antiphagocytic activity, toxin production, interactions with
immune system
n
Genetic changes due to:
p
High mutation rates of surface antigens
p
Acquisition of genetic elements
n
Molecular basis of microbial
pathogenicity (fig. 15.11)
Spread and Replication:
p
Molecular basis
p
Other factors
n
brain can influence immune
responses via
p
Shared chemical messengers with endocrine and
immune system
n
Host factors (fig. 15.12)
p
Host factors
Parasite survival strategies
Strategies to evade innate defenses
p
Killing or
avoiding being killed by phagocytes
p
Interfering with ciliary action
n
Impairment or destruction of
ciliary cells
p
Interfere with complement’s
alternative pathway
p
Producing iron binding
molecules
n
Siderophores
n
Take iron away from host iron-complexing
proteins
p
Blocking interferons
n
block actions of interferons (IFNa,
IFNb)
Strategies to evade adaptive defenses
p
More sophisticated
n
Lymphocytes (B and T cells) –
recognize shape or amino acid peptides
p
Capsules
§
recognized by B cell
à production of
antibodies, opsonization and phagocytosis
p
Peptides
§
presented on macrophage
surface à
detected by T cells à
cytotoxic and other defenses
p
Cause a rapid “hit-and-run”
infection
n
rhinoviruses, rotaviruses
p
Concealment of antigens from
host
n
Remain inside cells – latent
viruses (HSV)
n
Colonizing privileged sites
p
Hydatid cysts
§
form by Echinococcus
granulosus (tapeworm)
§
Liver, lung, brain
p
Integration into host DNA (retroviruses)
n
Mimicry – microbe mimics host
antigens
n
host produces autoantibodies
à
autoimmunity
p
Group A
beta-hemolytic streptococci – mimic cardiac muscle
à
rheumatic heart disease
n
Microbes cover surfaces with
host molecules
p
Antigenic variation
n
Mechanisms involved
p
Mutation
§
antigenic drift
p
Recombination
§
exchanged of genetic
information
p
Gene switching
§
switch from use of one
gene to another
Immunosuppression
p
Temporary or
long-lasting
p
Immunosuppresssive effects
n
actual infection of immune
cells
à impair cell
function or cell death
n
release immunosuppressive
molecules
Staphylococci toxins – potent T cell
mitogens
p
Interference with signaling
between immune cells
n
Fake molecules or fake cell
receptors for host molecules
p
Glycoprotein C (Herpes simplex virus)
–interferes with complement activation
n
Other proteins:
p
interfere with apoptosis
p
induce apoptosis
p
Interference with local
expression of immune response in tissues
n
Destruction of IgA by protease
n
Inactivation of complement
proteins
n
Production of Fc receptor
molecules (Fig 16.8)
p
Persistent infections
n
several forms:
p
Infectious (hep B)
p
Low infectivity (adenoviruses)
p
Non-infectious (latent, HSV)
n
Latent infections can be:
p
Associated with chronic diseases, cancers
p
Reactivated
Reactivation
p
Two stages in
reactivation
n
Stage A: resumption of viral
activity
p
HSV - triggered by sensory stimuli, fevers or
hormones
n
Stage B: Spread and replication
of reactivated virus
p
HSV – travels down axon to mucosal surface,
infect and spread forming a vesicle filled with viruses
p
Can be controlled by immune system
§
Cold sores – due to poor
lymphocyte response
§
Zoster – due to declining
cell-mediated responses
Pathologic consequences of infection
p
General scheme
p
Symptoms of disease caused by:
n
Microbe
n
Toxins
n
Induction of immune response
Direct tissue damage
Exotoxins
p
A-B toxins - consist of two
parts
p
A portion = Toxic or active enzyme
p
B portion = Binding component - Binds to
specific host cell receptors
n
Example: Diphtheria toxin
p
Exotoxins inactivated
à toxoid
(vaccine) à
diphtheria, tetanus
p
Pathologic
activation of natural immune mechanisms
n
Overactivity cause damage to
host tissues
p
Endotoxins
§
Activation of immune response
and clotting pathway (fig. 17.6)
p
Increased levels of TNF and activation of
complement
Hypersensitivity
p
lead to tissue damage due to
over-stimulation or prolonged response of adaptive immunity
-
Type III- Immune complex
-
Type IV hypersensitivity
-
Skin rashes
Pathologic consequences of infection
p
Viruses and cancer
n
Tumor viruses - cause malignant
changes within cells
n
Human cancers associated with
tumor viruses
|